Cure8
Krill oil supplementation alleviates clinical symptoms and improves intestinal barrier function with transcriptomic associations to cell adhesion molecule pathways in a mouse model of spontaneous chronic colitis
Frontiers in Nutrition

Cure8 research brief

Krill oil supplementation alleviates clinical symptoms and improves intestinal barrier function with transcriptomic associations to cell adhesion molecule pathways in a mouse model of spontaneous chronic colitis

2 min read
Diet and lifestyle Basic Science Researchers Clinicians Adult patients Inflammatory bowel disease

Why This Matters

Krill oil improved colitis signs and intestinal barrier markers in a mouse model and changed colon gene expression linked to cell adhesion—findings that may interest people tracking dietary or supplemental approaches for gut inflammation research.

The study is preclinical: it suggests biological plausibility but not proven benefit or safety in people with IBD.

Who Should Pay Attention

Researchers in IBD preclinical therapeutics and intestinal biology; clinicians and patients following dietary-supplement research for gut inflammation.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This animal study tested krill oil (KO) alone and combined with dexamethasone (DEX) in a spontaneous chronic colitis mouse model.

KO reduced disease severity, improved epithelial barrier integrity, and altered colonic gene expression linked to tight junctions and cell adhesion molecules; some benefits were similar to DEX and were enhanced when KO was combined with DEX.

The results come from a preclinical mouse model (Winnie mice) and report molecular changes (transcriptomics) in colon tissue rather than clinical outcomes in people. Measures included disease activity, histology, colonic permeability, protein expression of tight junctions, and RNA changes in barrier and cell-adhesion genes.

This work suggests KO has biological effects relevant to intestinal barrier function and immune cell recruitment in this model, supporting further research. It does not establish safety or efficacy in humans, dosing, or interactions with steroids.

Keep In Mind

Animal-model (mouse) study with transcriptomic analyses; results do not equal clinical evidence. Dosing, safety, and human effectiveness are unknown.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationFrontiers in Nutrition
PublisherFrontiers Media SA
AuthorsYingying Liu, Ainsley M Robinson, Kulmira Nurgali +1 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedAug 4, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →